The Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation is composed of 12 physicians with subspecialty oncology experience in specific hematologic malignancies and palliative care, which provides clinical expertise and research opportunities for leukemias and MDS, lymphomas, myeloma, and bone marrow transplantation related to these conditions.
Division of Hematologic Malignancies & Hematopoietic Stem Cell Transplantation
Leadership
Name:
Peirluigi Porcu, MD
Position:
- Director, Division of Hematologic Malignancies & Cellular Therapy
- Program Leader, Immune Cell Regulation & Targeting (IRT)
- Co-Director, Blood Cancer Center of Excellence (BCCE)
- Professor of Medical Oncology; Dermatology, & Cutaneous Biology
834 Chestnut Street
Suite 320
Philadelphia, PA 19107
Email:
Email Dr. Porcu
Contact Number(s):
For Patient Inquiries
New Patients: 1-800-JEFF-NOW
Existing Patients: 215-955-8874
Partnered Programs
Department of Medicine, Division of Hematology
The Division of Hematology supports Jefferson’s efforts in hemostasis/thrombosis, hemoglobinopathies, and other aspects of non-malignant hematology. The division of hematology co-directs the joint Hematology/Medical Oncology Fellowship Program with the Department of Medical Oncology and its hematologists frequently collaborate with the Division of Medical Oncology in both clinical and investigational activities. The Division of Hematology faculty are principally devoted to research into the causes of a wide variety of diseases of the blood and to the diagnosis and care of patients with blood and lymphatic diseases. They have competence in all areas of hematology, with particularly well-recognized depth and experience in:
- Diseases affecting blood platelets
- Hemorrhagic (bleeding) and thrombotic (clotting) disorders
- Other bone marrow disorders